240 related articles for article (PubMed ID: 20658466)
1. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data.
Ghouri N; Preiss D; Sattar N
Hepatology; 2010 Sep; 52(3):1156-61. PubMed ID: 20658466
[TBL] [Abstract][Full Text] [Related]
2. Perspective: nonalcoholic fatty liver disease and cardiovascular risk.
Nestel PJ; Mensink RP
Curr Opin Lipidol; 2013 Feb; 24(1):1-3. PubMed ID: 23298957
[TBL] [Abstract][Full Text] [Related]
3. Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults.
Chen SC; Tsai SP; Jhao JY; Jiang WK; Tsao CK; Chang LY
Sci Rep; 2017 Jul; 7(1):4649. PubMed ID: 28680048
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
5. Liver enzymes and risk of diabetes and cardiovascular disease: results of the Firenze Bagno a Ripoli (FIBAR) study.
Monami M; Bardini G; Lamanna C; Pala L; Cresci B; Francesconi P; Buiatti E; Rotella CM; Mannucci E
Metabolism; 2008 Mar; 57(3):387-92. PubMed ID: 18249212
[TBL] [Abstract][Full Text] [Related]
6. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
Kunutsor SK; Apekey TA; Khan H
Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
[TBL] [Abstract][Full Text] [Related]
7. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
Stepanova M; Younossi ZM
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
[TBL] [Abstract][Full Text] [Related]
8. Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study.
Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Blokzijl H; Gansevoort RT; Dullaart RP
Atherosclerosis; 2015 Nov; 243(1):138-47. PubMed ID: 26386210
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
[TBL] [Abstract][Full Text] [Related]
10. Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Williams KH; Sullivan DR; Nicholson GC; George J; Jenkins AJ; Januszewski AS; Gebski VJ; Manning P; Tan YM; Donoghoe MW; Ehnholm C; Young S; O'Brien R; Buizen L; Twigg SM; Keech AC
Metabolism; 2016 May; 65(5):783-793. PubMed ID: 27085785
[TBL] [Abstract][Full Text] [Related]
11. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.
Schindhelm RK; Diamant M; Dekker JM; Tushuizen ME; Teerlink T; Heine RJ
Diabetes Metab Res Rev; 2006; 22(6):437-43. PubMed ID: 16832839
[TBL] [Abstract][Full Text] [Related]
12. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2007 Jun; 56(6):792-8. PubMed ID: 17512312
[TBL] [Abstract][Full Text] [Related]
13. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
Wannamethee SG; Lennon L; Shaper AG
Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241
[TBL] [Abstract][Full Text] [Related]
14. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Sung KC; Ryan MC; Wilson AM
Atherosclerosis; 2009 Apr; 203(2):581-6. PubMed ID: 18774133
[TBL] [Abstract][Full Text] [Related]
15. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study.
Schindhelm RK; Dekker JM; Nijpels G; Bouter LM; Stehouwer CD; Heine RJ; Diamant M
Atherosclerosis; 2007 Apr; 191(2):391-6. PubMed ID: 16682043
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Pichiri I; Sorgato C; Zenari L; Bonora E
J Hepatol; 2010 Oct; 53(4):713-8. PubMed ID: 20619918
[TBL] [Abstract][Full Text] [Related]
18. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
[TBL] [Abstract][Full Text] [Related]
19. Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study.
Nguyen QM; Srinivasan SR; Xu JH; Chen W; Hassig S; Rice J; Berenson GS
Diabetes Care; 2011 Dec; 34(12):2603-7. PubMed ID: 21953798
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
